RCUS EPS Estimates
Arcus Biosciences, Inc.
$24.41
+$0.58(+2.43%)
49
Overall
60
Value
50
Tech
39
Quality
Market Cap
$3.03B
Volume
795.18K
52W Range
$13.61 - $31.74
Target Price
$38.75
RCUS EPS estimates: the consensus estimate for Arcus Biosciences, Inc.'s current fiscal year is -$3.53 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
RCUS EPS Estimates
- EPS estimate, current quarter
- $-0.93
- EPS estimate, next quarter
- $-0.91
- EPS estimate, current year
- $-3.53
- EPS estimate, next year
- $-3.24
- EPS growth, 3-year
- +3.93%
| Fiscal year | EPS |
|---|---|
| 2025 | $-3.29 |
| 2024 | $-3.14 |
| 2023 | $-4.15 |
| 2022 | $-3.71 |
| 2021 | $0.76 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | RCUS | $24.41 | +2.4% | 795.18K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |